Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

sanofi-aventis

Number 1 in France and in Europe, number 3 worldwide, in the pharmaceutical industry 7 major therapeutic areas
Cardiovascular, thrombosis, metabolic disorders, oncology, central nervous system, internal medicine and vaccines. About 100 000 employees worldwide.
Sales force of 35 000 medical visitors.
Present in 100 countries throughout the 5 continents. Consolidated sales of 27 billon euros and more than 4 billion euros Research & Development.


Contact Details:
174, av. de France
PARIS
75013
France
Tel:(33) 1 53 77 40 76
Fax:(33) 1 53 77 41 74
Email:webmaster@sanofi-aventis.com
WWW:

www.sanofi.com/




Recent Publications by sanofi-aventis:

[Decrease in Prostate Specific Antigen Secretion Correlated with Docetaxel-Induced Growth Inhibition and Apoptosis in Human Prostate Tumor Cells.]
The antitumor activity of docetaxel in human prostate tumor cells and...
19th November, 2009
Drug Safety Evaluation, Preclinical Development, R & D, sanofi-aventis K. Gan To Kagaku Ryoho. 2009 Nov;36(11):1863-1870.
{beta}-Tubulin-II Expression Strongly Predicts Outcome in Patients Receiving Induction Chemotherapy for Locally Advanced Squamous Carcinoma of the Head and Neck: A Companion Analysis of the TAX 324 Trial.
PURPOSE: TAX 324 was a phase III trial comparing induction chemotherapy...
18th November, 2009
University of Maryland Marlene and Stewart Greenebaum Cancer Center, J Clin Oncol. 2009 Nov 16.
DOI Direct Link
On the mechanism of microsomal prostaglandin E synthase type-2-A theoretical study of endoperoxide reaction with MeS(-).
The reaction pathways of deprotonation versus nucleophilic substitution...
17th November, 2009
Discovery Research, sanofi-aventis, 1041 Route 202/206 N, Bridgewater, NJ Bioorg Med Chem Lett. 2009 Oct 29.
DOI Direct Link
Relevance of the evaluation criteria used in clinical trials for Alzheimer's disease.
The roundtable 1 "Relevance of the evaluation criteria used in clinical...
17th November, 2009
Sanofi Aventis, Therapie. 2009 May-Jun;64(3):139-8. Epub 2009 Aug 13.
DOI Direct Link
No replication of genetic association between candidate polymorphisms and Alzheimer's disease.
Alzheimer's disease is a genetically complex disorder, for which new...
6th November, 2009
Biological Sciences Department, sanofi-aventis Recherche et Developpement, Neurobiol Aging. 2009 Nov 2.
DOI Direct Link

View more sanofi-aventis research publications.

Press Releases on sanofi-aventis:

BioPortfolio Logo
New GoMeals(TM) iPhone Application from sanofi-aventis U.S. to Help People with Diabetes Eat Healthy Anywhere, Anytime 19th November, 2009 sanofi-aventis U.S.
BRIDGEWATER, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today that GoMeals(TM), a new iPhone application (app) designed to help people living with diabetes make healthy food
Saatchi & Saatchi Wellness Wins Grand Clio and Gold Clio 17th November, 2009 Saatchi & Saatchi Wellness
NEW YORK, Nov. 17 /PRNewswire/ -- Saatchi & Saatchi Wellness took home the Grand Clio Award and won one of only two Gold Clio Healthcare awards handed out on Friday, November 13th at the inaugural
Sanofi-aventis Launches Major New Registry Including Over 10,000 Patients Worldwide With Atrial Fibrillation 16th November, 2009
PARIS, November 16 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the launch of the RealiseAF registry (Real Life global Survey Evaluating patients with Atrial
First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes 15th November, 2009
ORLANDO, Florida, November 15 /PRNewswire/ -- Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific
Euro RSCG Life Presents Proprietary Survey Insights at Food and Drug Administration Hearing on Pharmaceutical Promotion via Online and Social Media 12th November, 2009 Euro RSCG Worldwide
-- Even when it was not the direct catalyst for doctor-patient dialogue, two-thirds of all surveyed stated they found social media a helpful source of health information when they

BioNews Results for sanofi-aventis:

Pfizer's titanic competitor
Business Spectator:  Nov 16 2009 5:36AM Matching: sanofi aventi
Sanofi-Aventis to Establish Venture Capital Fund, Looking for 'Right Brain Activity'
Seeking Alpha:  Nov 15 2009 4:11PM Matching: sanofi aventi
Big Pharma Willing to Pay for Biotech Innovation
Seeking Alpha:  Nov 15 2009 4:10PM Matching: sanofi aventi
Sanofi-aventis, Regeneron Expand Antibody Pact
Contract Pharma:  Nov 14 2009 10:25PM Matching: sanofi aventi
Sanofi-aventis and Regeneron expand strategic Antibody Collaboration
Bionity.com:  Nov 14 2009 6:30PM Matching: sanofi aventi
Promote your company here: BioNewsCast - Press Release Distribution

View more sanofi-aventis news.

sanofi-aventis Patents:

US Patent No.Title
7531569 Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives
7550257 Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels
7550582 Polyamide nucleic acid derivatives and agents, and processes for preparing them
7553845 Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives
7557134 N-(heteroaryl)-1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV.sub.1 receptor ligands

View more sanofi-aventis patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 39 individuals from sanofi-aventis using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1001 times since April 2007, the link to the organisation's website has been followed 123 times

Recent Search Terms used to find this page: photosafety testing clinical | sanofi aventis 22 July 2009 | sanofi-aventis july 2009 | sanofi-aventis june 2009 | Discovery Research, Sanofi-Aventis Deutschland GmbH, | patent Glargine titration | Vitry research center of Sanofi-Aventis | What we have learned from the xaliproden Sanofi-aventis trials | xaliproden sanofi aventis | sanofi insulin like growth factor | .

Search for more companies in PARIS

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for sanofi-aventis

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.